Bayer shares sag after U.S. jury verdict in Roundup cancer trial

science

science / science 244 Views comments

Bayer shares sag after U.S. jury verdict in Roundup cancer trialBayer AG shares sank to their lowest in almost seven years on Thursday after a U.S. jury awarded $80 million to a man who claimed use of the group's weed killer Roundup caused his cancer, with thousands of similar lawsuits looming. The jury in San Francisco federal court on Wednesday found Bayer liable because its Monsanto unit did not warn plaintiff Edwin Hardeman of the herbicide's alleged cancer risks.


Comments